Related references
Note: Only part of the references are listed.The orphan receptor GPR55 is a novel cannabinoid receptor
E. Ryberg et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-α agonist, modulates carrageenan-induced paw edema in mice
Giuseppe D'Agostino et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase
Sandor Batkai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Attenuation of allergic contact dermatitis through the endocannabinoid system
Meliha Karsak et al.
SCIENCE (2007)
Cannabinoid-2 receptor mediates protection against hepatic ischemia/reperfusion injury
Sandor Batkai et al.
FASEB JOURNAL (2007)
The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept
Arpad Szallasi et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Biochemistry and pharmacology of endovanilloids
Katarzyna Starowicz et al.
PHARMACOLOGY & THERAPEUTICS (2007)
Involvement of the cannabinoid CB2 receptor and its endogenous ligand 2-arachidonoylglycerol in oxazolone-induced contact dermatitis in mice
Saori Oka et al.
JOURNAL OF IMMUNOLOGY (2006)
Inactivation of N-acyl phosphatidylethanolamine phospholipase D reveals multiple mechanisms for the biosynthesis of endocannabinoids
D Leung et al.
BIOCHEMISTRY (2006)
The transient receptor potential vanilloid 1: Role in airway inflammation and disease
P Geppetti et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Endocannabinoid, anandamide in gingival tissue regulates the periodontal inflammation through NF-κB pathway inhibition
Y Nakajima et al.
FEBS LETTERS (2006)
Evidence for a novel protective role of the vanilloid TRPV1 receptor in a cutaneous contact allergic dermatitis model
A Bánvölgyi et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Involvement of cannabinoid CB2 receptor-mediated response and efficacy of cannabinoid CB2 receptor inverse agonist, JTE-907, in cutaneous inflammation in mice
Y Ueda et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions:: Review of the available pre-clinical data, and first human studies
NA Darmani et al.
NEUROPHARMACOLOGY (2005)
Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase
K Tsuboi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution
CN Serhan
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2005)
The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide
J Lo Verme et al.
MOLECULAR PHARMACOLOGY (2005)
The endogenous cannabinoid system protects against colonic inflammation
F Massa et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Expression of vanilloid receptor subtype 1 in cutaneous sensory nerve fibers, mast cells, and epithelial cells of appendage structures
S Ständer et al.
EXPERIMENTAL DERMATOLOGY (2004)
Massive accumulation of N-acylethanolamines after stroke.: Cell signalling in acute cerebral ischemia?
C Berger et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Characterization of the human HCN1 channel and its inhibition by capsazepine
CH Gill et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
New perspectives in the studies on endocannabinoid and cannabis: 2-arachidonoylglycerol as a possible novel mediator of inflammation
T Sugiura et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2004)
Selective antiepileptic effects of N-palmitoylethanolamide, a putative endocannabinoid
AH Sheerin et al.
EPILEPSIA (2004)
Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neurons
TJ Price et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Cannabinoids ablate release of TNFα in rat microglial cells stimulated with lypopolysaccharide
F Facchinetti et al.
GLIA (2003)
Cannabimimetic activity, binding, and degradation of stearoylethanolamide within the mouse central nervous system
M Maccarrone et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2002)
Binding, degradation and apoptotic activity of stearoylethanolamide in rat C6 glioma cells
M Maccarrone et al.
BIOCHEMICAL JOURNAL (2002)
'Entourage' effects of N-acyl ethanolamines at human vanilloid receptors.: Comparison of effects upon anandamide-induced vanilloid receptor activation and upon anandamide metabolism
D Smart et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
Cannabinoid receptor-inactive N-acylethanolamines and other fatty acid amides:: metabolism and function
HHO Schmid et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2002)
An anorexic lipid mediator regulated by feeding
FR de Fonseca et al.
NATURE (2001)
Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors
L De Petrocellis et al.
FEBS LETTERS (2001)
Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells
V Di Marzo et al.
BIOCHEMICAL JOURNAL (2001)
The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase
L De Petrocellis et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide
A Calignano et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)